Transcription factor MAZ activates the transcription of hypomethylated TYMP in ccRCC
Yihan Dong1, Xinyu Liu1, Jiaxin Li1
1School of Medical Technology, Tianjin Medical University, Tianjin, 300203, China.
Abstract:
Clear cell renal cell carcinoma (ccRCC) is a highly malignant tumor characterized by a significant propensity for recurrence and metastasis. DNA methylation has emerged as a critical epigenetic mechanism with substantial utility in cancer diagnosis. In this study, multi-omics data were utilized to investigate the target genes regulated by the transcription factor MYC-associated zinc finger protein (MAZ) in ccRCC, leading to the identification of thymidine phosphorylase (TYMP) as a gene with notably elevated expression in ccRCC. The interaction between MAZ and TYMP was confirmed through chromatin immunoprecipitation (ChIP) assays and bioinformatics analysis. It was found that the binding of MAZ to the TYMP promoter is associated with the methylation status of this promoter region. Furthermore, the methylation of the TYMP promoter appears to be correlated with both the clinicopathological stage and overall survival of ccRCC patients. Further exploration of genes within the "nucleotide metabolism" pathway, identified through Gene Ontology (GO) enrichment analysis, revealed that uridine phosphorylase 1 (UPP1) interacts with TYMP. Interestingly, UPP1 was also shown to be activated by MAZ, suggesting a coordinated regulatory mechanism. Based on these findings, we propose that the TYMP-UPP1 complex, co-regulated by MAZ, plays a pivotal role in nucleotide metabolism in ccRCC. These results suggest that TYMP may contribute to the pathophysiology of ccRCC and that promoter methylation offers potential as a prognostic indicator, providing novel insights into the molecular underpinnings of ccRCC and potential avenues for therapeutic intervention.
Insights
Clear cell renal cell carcinoma (ccRCC) involves elevated thymidine phosphorylase (TYMP) expression, regulated by MAZ. TYMP promoter methylation correlates with ccRCC progression and patient survival, offering prognostic potential.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Clear cell renal cell carcinoma (ccRCC) is an aggressive malignancy with high recurrence and metastasis rates.
- DNA methylation is a key epigenetic mechanism crucial for cancer diagnosis and progression.
- Understanding gene regulation in ccRCC is vital for developing targeted therapies.
Purpose of the Study:
- To investigate target genes regulated by MYC-associated zinc finger protein (MAZ) in ccRCC using multi-omics data.
- To identify the role of thymidine phosphorylase (TYMP) and its regulatory mechanisms in ccRCC.
- To explore the potential of TYMP promoter methylation as a prognostic biomarker.
Main Methods:
- Multi-omics data analysis to identify MAZ-regulated genes.
- Chromatin immunoprecipitation (ChIP) assays to confirm MAZ-TYMP interaction.
- Bioinformatics analysis and Gene Ontology (GO) enrichment to study gene pathways and interactions.
- Analysis of TYMP promoter methylation status in relation to clinicopathological data.
Main Results:
- Thymidine phosphorylase (TYMP) was identified as a gene with significantly elevated expression in ccRCC.
- MAZ directly binds to the TYMP promoter, and this binding is influenced by promoter methylation status.
- TYMP promoter methylation correlates with ccRCC clinicopathological stage and overall patient survival.
- Uridine phosphorylase 1 (UPP1) was found to interact with TYMP and is also activated by MAZ, indicating a coordinated regulatory network in nucleotide metabolism.
Conclusions:
- The TYMP-UPP1 complex, co-regulated by MAZ, plays a significant role in nucleotide metabolism within ccRCC.
- TYMP contributes to ccRCC pathophysiology, and its promoter methylation serves as a potential prognostic indicator.
- These findings provide insights into ccRCC molecular mechanisms and suggest potential therapeutic targets.
More Related Videos
Related Concept Videos
Master Transcription Regulators
Co-activators and Co-repressors
Epigenetic Regulation
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
RNA Polymerase II Accessory Proteins
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...


